Envision Healthcare (NYSE:EVHC) has been assigned a $41.00 price target by research analysts at Jefferies Group in a note issued to investors on Tuesday. The firm currently has a “buy” rating on the stock. Jefferies Group’s price objective would indicate a potential upside of 21.09% from the company’s previous close.
Several other research analysts also recently commented on EVHC. Robert W. Baird cut their target price on Envision Healthcare from $70.00 to $35.00 and set an “outperform” rating on the stock in a report on Friday, November 3rd. Oppenheimer cut their target price on Envision Healthcare from $77.00 to $40.00 and set an “outperform” rating on the stock in a report on Thursday, November 2nd. KeyCorp set a $40.00 target price on Envision Healthcare and gave the stock a “buy” rating in a report on Tuesday, November 14th. Bank of America downgraded Envision Healthcare from a “buy” rating to a “neutral” rating and set a $32.00 target price on the stock. in a report on Thursday, November 2nd. Finally, Cantor Fitzgerald downgraded Envision Healthcare from an “overweight” rating to a “neutral” rating and set a $30.00 target price on the stock. in a report on Wednesday, November 1st. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus price target of $44.19.
Shares of Envision Healthcare (EVHC) opened at $33.86 on Tuesday. The company has a current ratio of 3.01, a quick ratio of 3.00 and a debt-to-equity ratio of 0.89. Envision Healthcare has a twelve month low of $23.77 and a twelve month high of $73.00. The firm has a market capitalization of $4,146.50, a price-to-earnings ratio of 10.59, a P/E/G ratio of 0.89 and a beta of 0.57.
Envision Healthcare declared that its Board of Directors has initiated a share repurchase plan on Monday, September 18th that allows the company to repurchase $250.00 million in outstanding shares. This repurchase authorization allows the company to purchase up to 4.5% of its shares through open market purchases. Shares repurchase plans are generally a sign that the company’s board of directors believes its shares are undervalued.
Several large investors have recently made changes to their positions in the company. Vanguard Group Inc. lifted its stake in shares of Envision Healthcare by 1.8% in the 2nd quarter. Vanguard Group Inc. now owns 11,471,402 shares of the company’s stock valued at $718,912,000 after purchasing an additional 204,584 shares during the period. BlackRock Inc. lifted its stake in shares of Envision Healthcare by 2.1% in the 2nd quarter. BlackRock Inc. now owns 7,345,283 shares of the company’s stock valued at $460,330,000 after purchasing an additional 147,652 shares during the period. Maverick Capital Ltd. lifted its stake in shares of Envision Healthcare by 66.2% in the 2nd quarter. Maverick Capital Ltd. now owns 5,093,292 shares of the company’s stock valued at $319,197,000 after purchasing an additional 2,028,026 shares during the period. Janus Henderson Group PLC lifted its stake in shares of Envision Healthcare by 0.3% in the 3rd quarter. Janus Henderson Group PLC now owns 3,958,329 shares of the company’s stock valued at $177,927,000 after purchasing an additional 13,242 shares during the period. Finally, OZ Management LP acquired a new position in shares of Envision Healthcare in the 3rd quarter valued at about $131,987,000.
COPYRIGHT VIOLATION WARNING: This news story was originally reported by American Banking and Market News and is the sole property of of American Banking and Market News. If you are accessing this news story on another publication, it was illegally copied and reposted in violation of US and international trademark and copyright law. The legal version of this news story can be accessed at https://www.americanbankingnews.com/2017/12/19/envision-healthcare-evhc-pt-set-at-41-00-by-jefferies-group.html.
About Envision Healthcare
Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.
